Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Typical subcutaneous dosing ranges from 1-3 mg daily or 3-5 times per week, often cycled in 8-12 week protocols with 4-week breaks to prevent receptor downregulation or copper accumulation
This possibility is reflected in its clinical plasma half-life, which in the first-in-human study was measured to 85104 hours when administered at a dosage of 250 mg/kg [224]
Detection times may vary based on dosage, metabolism, and frequency of use
The part that actually matters is where the research goes from here
The FDA has banned compounding and injection of peptides like GHK-Cu due to safety concerns
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
